UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000023763
Receipt number	R000018461
Scientific Title	The Phase II study on the efficacy and safety of weekly nab-paclitaxel with 3 rd line therapy or more of advanced or recurrent non-small cell lung cancer after disease progression on 2nd line therapy or more
Date of disclosure of the study information	2016/08/25
Last modified on	2016/08/25 16:11:13

---